Michael Landsittel, CHIEF FINANCIAL OFFICER at Blueprint Medicines Corp (BPMC), sold 4,750 shares at $56.19 ($278K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $278k BPMC by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.27 | 1,328 | $80K | 28.8% |
| 2 | $60.27 | 1,328 | $80K | 28.8% |
| 3 | $56.19 | 1,047 | $59K | 21.2% |
| 4 | $56.19 | 1,047 | $59K | 21.2% |
| Total | $58.47 avg | 4,750 | $278K | 100% |
| Filing → |
| BPMC | SELL | 2024-05-17 | $824K | — | Filing → |
| BPMC | SELL | 2024-05-06 | $1.1M | — | Filing → |
| BPMC | SELL | 2024-04-01 | $475K | — | Filing → |